ドナーの心臓における心筋機能不全. 可能性のある病因学
V J Owen1, P B Burton, M C Michel
1Cardiothoracic Surgery, National Heart and Lung Institute at Imperial College School of Medicine, London, UK. v.j.owen@ic.ac.uk
Circulation
|May 20, 1999
まとめ
抑制性Gタンパク質ギアルファ活性の増加は,急性欠陥のドナー心臓の収縮性の低下に寄与する. これは,カルシウム処理タンパク質とβ-アドレノ受容体の密度の変化と対照的であるが,これらは一般的な原因ではなかった.
科学分野:
- 心臓病学 心臓病学
- 分子生物学は分子生物学である.
- 移植科学 移植科学とは
背景:
- 未使用のドナー心臓は,しばしば心筋機能不全を示し,移植に適さない.
- これらの心臓における急性心不全の根本的なメカニズムは不明である.
- この研究では,カルシウム処理タンパク質,β-アドレノ受容体の密度,および抑制性Gタンパク質のGアルファを含む潜在的な原因を調査しています.
研究 の 目的:
- 急性欠陥のドナー心臓における収縮機能障害の分子基礎を決定する.
- 未使用のドナー心臓の変異を,最終段階の衰弱と不衰弱の心臓の変異と比較する.
- 心臓機能障害に寄与する主要なタンパク質標的を特定する.
主な方法:
- 未使用のドナー心臓 (エジェクション分数<30%),終期の衰弱心臓,および不衰弱心臓からの心筋サンプルを分析.
- トラベキュラと孤立したミオサイトにおけるイノトロプ的機能のインビトロ評価.
- 特定のカルシウム処理タンパク質 (SERCA,NCX) の定量化,ベータアドレノ受容体密度,およびギアルファ活性.
主要な成果:
- 未使用のドナー心臓は,心臓の衰弱に匹敵する収縮機能不全を示した.
- サルコプラズマ網膜のカルシウム-ATPaseとナトリウム-カルシウム交換器の豊富な変化は,両方のグループに共通するものではありませんでした.
- ベータアドレノ受容体の密度は,衰弱した心臓では減少したが,未使用のドナー心臓では減少しなかった.
- 未使用のドナーと衰弱した心臓の両方において,抑制性Gタンパク質ギアルファ活性の増加が観察されました.
結論:
- 高いギアルファ活性は,急性欠陥のドナー心臓の収縮性障害の重要な要因である.
- この発見は,カルシウム処理タンパク質の変化やβ-アドレノ受容体の密度の変化からメカニズムを区別する.
- Gialphaをターゲットにすることは,ドナー心臓の心臓機能を保存するための治療的可能性を提示する可能性があります.
関連する概念動画
Cell-mediated Immune Responses
Overview
Bone Marrow Sampling and Transplants
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Imbalances in Cardiac Output
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Tissue Transplantation
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Rheumatic Heart Disease I: Introduction
Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
Kidney Transplant I: Introduction
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...


